Enter assignee name

Forward Citations = 4

Loading Chart...

3 inventors (with patents filed for the assignee):

Barry Bleske (7 out of 7 patents)

Ted William Lanpher (6 out of 7 patents)

Scott Lyman (5 out of 5 patents)

7 patents: Sort by Forward Citations

1. 12414916 - Dry powder formulations of epinephrine and associated methods (2025-09-16),

2. 12102629 - Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides (2024-10-01),

3. 12097287 - Dry powder formulations of epinephrine and associated methods (2024-09-24),

4. 12005185 - Medical counter measures including dry powder formulations and associated methods (2024-06-11),

5. 11872308 - Dry powder formulations of epinephrine and associated methods (2024-01-16),

6. 11617716 - Dry powder formulations of epinephrine and associated methods (2023-04-04),

7. 11433063 - Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides (2022-09-06),

Belhaven Biopharma, Inc. is a biotechnology company focused on developing novel therapies for the treatment of rare and orphan diseases. With a strong emphasis on research and innovation, Belhaven is dedicated to improving the lives of patients through breakthrough treatments. The company's pipeline includes promising candidates for various rare diseases, making them a promising player in the biopharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

7 Patents

#99 in Durham, NC

#835 in North Carolina

#38,778 in US

Durham, NC, United States of America

Belhaven Biopharma, Inc.

Forward Citations = 4

3 inventors:

Barry Bleske (7 out of 7 patents)

Ted William Lanpher (6 out of 7 patents)

Scott Lyman (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com